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Abstract: Mitochondria-associated ER membranes (MAMs) are crucial for lipid transport and
synthesis, calcium exchange, and mitochondrial functions, and they also act as signaling platforms.
These contact sites also play a critical role in the decision between autophagy and apoptosis with
far reaching implications for cell fate. Vascular smooth muscle cell (VSMC) apoptosis accelerates
atherogenesis and the progression of advanced lesions, leading to atherosclerotic plaque vulnerability
and medial degeneration. Though the successful autophagy of damaged mitochondria promotes
VSMC survival against pro-apoptotic atherogenic stressors, it is unknown whether MAMs are
involved in VSMC mitophagy processes. Here, we investigated the role of the multifunctional MAM
protein phosphofurin acidic cluster sorting protein 2 (PACS-2) in regulating VSMC survival following
a challenge by atherogenic lipids. Using high-resolution confocal microscopy and proximity ligation
assays, we found an increase in MAM contacts as in PACS-2-associated MAMs upon stimulation
with atherogenic lipids. Correspondingly, the disruption of MAM contacts by PACS-2 knockdown
impaired mitophagosome formation and mitophagy, thus potentiating VSMC apoptosis. In conclusion,
our data shed new light on the significance of the MAM modulatory protein PACS-2 in vascular
cell physiopathology and suggest MAMs may be a new target to modulate VSMC fate and favor
atherosclerotic plaque stability.
Keywords: PACS-2; mitochondria-associated ER membranes (MAMs); mitochondria; mitophagy;
apoptosis; atherosclerosis; vascular smooth muscle cell
1. Introduction
The close membrane appositions between the mitochondrion and the endoplasmic reticulum (ER)
form 10–50 nm wide contact sites commonly referred as mitochondria-associated ER membranes (MAMs)
or mitochondria-ER contacts (MERCs) [1]. Such contact sites support the inter-organelle communication
involved in the detection of extracellular inputs and stressful situations. MAMs have been described in
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species ranging from yeast to mammals [2]. Several studies identified that MAMs are crucial for processes
including lipid transport and synthesis, calcium exchange, mitochondrial functions, and apoptosis [3–5].
A large number of ER and mitochondria-associated proteins have been identified in MAMs and described to
participate as molecular tethers (including Ca2+ ion channels) such as inositol 1,4,5-trisphosphate receptor
type 1 (IP3R1) and voltage-dependent anion channel 1 (VDAC1); chaperones like the glucose-regulated
protein 75 (Grp75); proteins involved in the regulation of mitochondrial shape and dynamic, including
dynamin-related protein 1 (DRP1) and mitofusin 2 (MFN2); and the multifunctional sorting protein,
phosphofurin acidic cluster sorting protein 2 (PACS-2) [6].
The involvement of MAMs in the critical balance between cell survival and death has been recently
suggested, particularly because these contact sites play a vital role in modulating the decision between
autophagy and apoptosis. For instance, the anti-apoptotic protein Bcl-2 binds to the autophagy protein
Beclin-1 on the ER membrane. The Bcl-2-Beclin-1 complex can regulate the switch between apoptotic
and autophagic pathways [4]. In addition, the early autophagosomal marker, ATG5, localizes to
punctae on mitochondria and are followed by the late autophagosomal marker, LC3 [7,8]. Likewise,
the pre-autophagosome/autophagosome marker ATG14 complex translocates to an ER-based early
autophagy membrane assembly zone associated with MAMs where it is maintained, in part, via MFN2
and PACS-2 [7,8]. Indeed, PACS-2 controls the apposition of mitochondria with the ER, as depletion of
PACS-2 causes BAP31-dependent mitochondria fragmentation and uncoupling from the ER [9]. Moreover,
PACS-2 has been shown to control cell fate by translocating Bid to mitochondria [9] or by promoting ataxia
telengectasia (ATM) to drive nuclear factor kappa B (NF-κB) activation and the induction of anti-apoptotic
Bcl-xL [10]. PACS-2 was also identified as an essential TNF-related apoptosis-inducing ligand (TRAIL)
effector, one required for killing tumor cells in vitro and virally infected hepatocytes in vivo [11].
Vascular smooth muscle cells (VSMCs) control multiple attributes of vessel homeostasis, including
contraction, dilation, and vessel remodeling. Consequently, VSMCs are a major cellular determinant
of arterial wall disease. In atherosclerosis, VSMCs are the first to carry lipid retention and lipid
overload through foam cell formation and death. Because VSMCs contribute to the synthesis of matrix
components and form the fibrous cap of atherosclerotic plaques, the induction of VSMC apoptosis
increases plaque vulnerability and medial degeneration, leading to plaque thrombogenicity [12].
However, the mechanisms controlling plaque stability versus plaque rupture are complex, and the
oxidizing and inflammatory environment generated by the presence of pro-atherogenic factors
(low-density lipoproteins (LDL) and oxidized lipids, oxidative stress, cytokines) can trigger either
pro-survival or pro-death processes which are concomitantly activated in cells [13].
The induction of autophagy plays an important role in the response of VSMCs to various
atherogenic stressors, such as oxidized lipids [14]. Though autophagy is often considered to be a
non-selective degradative pathway [15], the selective autophagy of damaged organelles is critical
for the maintenance of cellular homeostasis. Indeed, damaged mitochondria can also be discarded
by a specific form of autophagy known as mitophagy [16]. Mitophagy takes place in specific
developmental processes, such as the maturation of erythrocytes [17], and it also follows pathological
mitochondrial damage in order to eliminate dysfunctional mitochondria and prevent cell death [18].
Alterations in mitochondrial morphology (fragmentation and remodeling) and function (decline in
mitochondrial membrane potential and increase in radical production) are observed during the early
stages of apoptosis. These events are known to be prerequisites for the initiation of mitophagy [19,20],
which promotes cell survival by preventing the release of pro-apoptotic factors into the cytosol and the
activation of downstream cell death pathways [21].
The indication that mitophagy occurs at MAM contacts was first shown in yeast where the
ER-mitochondria encounter structure (ERMES) complex, which tethers the ER and mitochondria,
is colocalized with the site of mitophagosome biogenesis [22]. We previously reported the importance
of mitophagy in VSMC fate upon apoptotic stress [23]. However, the relevance of MAM formation
and function in the regulation of VSMC mitophagy and cell death is unknown. Here, we report
that the tether-inducing protein PACS-2 accumulates at mitochondria-ER contact sites in human
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VSMCs challenged with oxidized low-density lipoproteins (LDL) and thereby increases the MAM
contacts. The disruption of MAM contacts by PACS-2 deletion impairs mitophagosome formation and
mitophagy, thus potentiating VSMC apoptosis. These findings suggest that MAM-associated PACS-2
is a critical regulator of human VSMCs fate during oxidized LDL-induced mitophagy.
2. Materials and Methods
2.1. Reagents and Antibodies
Oligomycin (O4876), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (C2920),
antimycin A (A8674), rotenone (R8875), carbonyl cyanide 3-chlorophenylhydrazone (CCCP) (C2759),
bafilomycin A1 (B1793), sodium pyruvate (P5280), and glucose (G7021) were purchased from
Sigma-Aldrich (St. Quentin Fallavier, France). MitoTracker Deep Red (M22426) and l-glutamine
(25030-024) were purchased from ThermoFisher Scientific (Illkirch, France). Cyto-ID (ENZ-51031) was
purchased from Enzo Life Sciences (Villeurbanne, France). Anti-Mitofusin 2 (rabbit, 9482), anti-Grp75
(rabbit, 3593), anti-LC3B (rabbit, 2775), and anti-Myc (mouse, 2276) were from Cell Signaling Technology
(Saint Quentin Yvelines, France). Anti-Tom20 (rabbit, sc-11415), anti-Tom20-AF488 (rabbit, sc-17764),
anti-Parkin (mouse, sc-32282), and anti-Ero1-Lα (mouse, sc-365526) were from Santa Cruz Biotechnology
(Heidelberg, Germany). Anti-VDAC1 (mouse, ab14734), anti-Parkin (rabbit, ab15954), and anti-Beclin-1
(mouse, ab114071) were from Abcam (Paris, France). Anti-KDEL (mouse, ADI-SPA-827-D) was from Enzo
Life Sciences. Anti-PACS-2 (rabbit, 19508-1-AP) was from Proteintech (Manchester, UK), and anti-PACS-2
(rabbit, clone 18143) was previously reported [9]. Anti-IP3R1 (rabbit, 07-1213) was from Merck Millipore
(Molsheim, France). Anti-β-actin (mouse, A2228) and anti-P62 (rabbit, P0067) were from Sigma-Aldrich.
2.2. Cell Culture and Transfection
Human primary VSMCs were obtained from the mesenteric arteries of postmortem organ donors
in agreement with the French “Agence de Biomédecine” and the ethics committee of the University
Hospital of Toulouse, France. Briefly, the arteries were cut longitudinally, and small pieces of the
media were carefully stripped from the vessel wall and cultured until VSMCs migrated from the
explants (1–2 weeks) and could be passed (3 weeks after the first appearance of cells) [24]. The VSMC
phenotype was verified with a specific α-smooth muscle actin staining. The primary cultured human
VSMCs were then used to generate an immortalized cell line by using a SV40T antigen [23]. SV40T and
contractile phenotype markers-expressing human VSMC were maintained in a Dulbecco’s modified
Eagle’s medium (DMEM, 61965-026, ThermoFisher Scientific, Illkirch, France) supplemented with
10% fetal calf serum, penicillin (100 U/mL), and streptomycin (10 µg/mL) at 37 ◦C under a humidified
atmosphere with 5% CO2. Human VSMCs were used between passage 7 and 17 for all experiments,
and they were cultured in DMEM without serum before each experiment.
Mouse embryonic fibroblasts (MEFs) deleted for the PACS-2 protein and isolated from PACS-2−/−
mice were kindly provided by Professor Gary Thomas (Department of Microbiology and Molecular
Genetics, University of Pittsburg, Pittsburg, USA) and cultivated as human VSMC in complete DMEM
with serum and antibiotics [11].
For siRNA transfection, ON-TARGET plus Human PACS-2 (L-022015-01), ON-TARGET plus
Human Mfn2 (L-012961-00), and ON-TARGET plus Human PRKN (L-003603-00) from Dharmacon
(Compiegne, France) were, respectively, directed against PACS-2, MFN2, and Parkin, which were then
transfected (200–400 nM) in an Opti-MEM medium (31985-047, ThermoFisher Scientific) using the
Hiperfect reagent (301705, Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
For plasmids transfection, the pcDNA3-PACS-2 plasmid was kindly provided by Professor Gary
Thomas (Department of Microbiology and Molecular Genetics, University of Pittsburg, Pittsburg, USA),
and the SIN-PGK-MitoTimer plasmid was kindly provided by Dr. Kevin Richetin (Lausanne University
Hospital, Lausanne, Switzerland). Cells were transiently transfected (0.5 µg/mL) in a DMEM
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serum-free medium using the GeneCellin reagent (GC1000, Eurobio, Les Ulis, France) according
to the manufacturer’s instructions.
2.3. LDL Isolation and Oxidation
LDL from normal human pooled sera were prepared by ultracentrifugation and dialyzed against
phosphate buffered saline (PBS) containing 100 µM ethylenediaminetetraacetic acid (EDTA). The LDL
pool was then diluted to 2 g/L with PBS into a final volume of 3 mL. LDL were mildly oxidized by
UV-C for 2 h in the presence of 5 µM CuSO4, as previously reported [25]. Oxidized LDL contained
4.2–7.4 nmoles of TBARS (thiobarbituric acid-reactive substances)/µg ApoB. Relative electrophoretic
mobility (REM) and 2,4,6-trinitrobenzenesulfonic acid (TNBS) reactive amino groups were 1.2–1.3 times
and 85–92% of native LDL, respectively.
2.4. Cell Immunofluorescence: Classic and High-Resolution Stimulated Emission Depletion (STED)
Confocal Microscopy
After the treatments, cells grown on glass coverslips were fixed in PBS-4% paraformaldehyde (PFA)
for 10 min at room temperature (RT) and then washed and permeabilized with PBS-0.1% TritonX100
for 10 min at RT. After blocking with PBS containing 3% bovine serum albumin (BSA) for 45 min
at RT, cells were incubated with the indicated primary antibodies (1/100) for 1 h at RT and revealed
with Alexa Fluor-conjugated secondary antibodies (1/1000) for 1 h at RT. Nuclei were labeled with
4′,6-diamidino-2-phenylindole (DAPI) and cells were mounted with a fluorescent mounting medium
(DAKO, 3023). For classic confocal microscopy, Alexa Fluor goat anti-mouse (A11001), anti-rabbit
(A11008) 488, goat anti-mouse (A11003), anti-rabbit (A11010) 546, and anti-rabbit (A21244) 647 from
ThermoFisher Scientific were used, and images were acquired on a Zeiss LSM 780 inverted fluorescence
confocal microscope. For high-resolution stimulated emission depletion (STED) microscopy, the same
immunocytochemistry protocol was used, but the cells were grown on thinner glass coverslips, primary
antibodies were incubated at 1/50, coverslips were mounted with Mowiol and F(ab’)2 goat anti-rabbit
594 (A11072, ThermoFisher Scientific, Illkirch, France), and goat anti-mouse Abberior STAR RED
(52283, Sigma-Aldrich, St. Quentin Fallavier, France) were used as specific secondary antibodies.
Images were acquired on a Leica SP8 inverted fluorescence confocal microscope equipped with a STED
module. Between 8 and 20 images of one cell were acquired (63×, zoom 3 or 5) per condition for
each experiment, and all images were analyzed using Image J software. The colocalization analysis
between the different channels was realized by measuring both Pearson’s colocalization coefficient
(perinuclear cell area) before binarization and objects colocalization area after binarization. For this
latter measure, images were first thresholded and binarized for each channel. Then, the objects area for
each channel, as their area fraction that colocalizes with objects of another channel, were obtained with
Set Measurements and Analyse Particules tabs on Image J software. These values of area fraction were
obtained for each object of each channel and corresponded to the percentage of each object area in one
channel colocalized with objects in the other channel. For the colocalization measure between three
channels, a colocalized binary mask of two channels was first created. Then, the corresponding absolute
area value of colocalization was calculated for each object in an excel file, and the total sum of these
area values per image were finally used to measure the parameters of colocalization between channels.
2.5. Duolink® In Situ Proximity Ligation Assay
Duolink® in situ proximity ligation assay (PLA) is a powerful technique allowing for the detection,
visualization, and quantification of protein–protein interactions (<40 nm) as individual fluorescent dots
by microscopy. This technology combines immunodetection and molecular biology techniques based on
antibodies affinity and the amplification of oligonucleotidic sequences coupled to secondary antibodies.
After the treatments, cells were fixed and permeabilized as described for cell immunofluorescence.
Blocking (1 h at RT) and incubation with primary (1/100, 1 h at RT) and secondary antibodies (1/5, 1 h
at 37 ◦C) using anti-rabbit PLUS (DUO92002) and anti-mouse MINUS (DUO92004) kits, followed by
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ligation and amplification steps using the detection reagents red kit (DUO92008), were performed
according to the manufacturer’s protocol (Sigma-Aldrich, St. Quentin Fallavier, France). Coverslips
were mounted with a mounting medium containing DAPI (DUO82040) and fixed with varnish.
Fluorescence was analyzed on a Zeiss LSM 780 inverted fluorescence confocal microscope, 5–10 fields
of about 15 cells per condition for each experiment were acquired, and the number of interactions per
cell was then analyzed using Image J software.
2.6. Western-Blot Analysis
After the treatments, cells were washed in cold PBS, and proteins were extracted in a solubilizing
buffer (10 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl
sulfate, 1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 5 mM sodium fluoride, 1 mM
phenylmethylsulfonyl fluoride, 1 µg/mL leupeptin, 1 µg/mL aprotinin) for 30 min on ice. For western-blot
analyses, 30 µg of protein cell extracts were resolved by SDS-polyacrylamide gel electrophoresis
and transferred onto polyvinylidene fluoride (PVDF) membranes (Immobilon, IPVH 00010, Merck
Millipore, Molsheim, France). Subsequently, membranes were probed with the indicated primary
antibodies and developed with the secondary antibodies coupled to horseradish peroxidase using an ECL
chemoluminescence kit (RPN21016, Amersham, Pittsburgh, PA, USA) and a Chemidoc Touch system
(Bio-Rad, Marnes-la-Coquette, France). Membranes were stripped and reprobed with an anti-β-actin
antibody to control the equal loading of proteins. The quantification of the protein bands was performed
using Image Lab software (Image Lab 6.0.1, Bio-Rad, Marnes-la-Coquette, France).
2.7. Mitochondrial Complexes I and III Activity Assay
The specific activity of complexes I and III was measured as rotenone-sensitive NADH cytochrome c
reductase activity according to Spinazzi and coll [26]. After treatment, cells plated in 24-well plates were
scraped and centrifuged in cold PBS containing proteases inhibitors. The cell pellet was resuspended in
a mannitol buffer with pH 7.2 (mannitol 225 mM, saccharose 75 mM, Tris HCl 10 mM, EDTA 0.1 mM),
frozen in liquid nitrogen, and kept at −80 ◦C. After protein content determination for each condition, 40
µL of cellular homogenate (0.2 µg/mL final concentration) was added to 1940 µL of a reaction medium
(potassium phosphate buffer pH 7.5 50 mM, BSA 1 mg/mL, cytochrome c 100 µM, KCN 1 mM). Five µL
rotenone (2.5 mM) was added to 900 µL of a reaction medium and incubated at 37 ◦C for 5 min before the
reaction was started by adding 100 µL NADH (2 mM), and 550 nm absorbance was read every 15 s for 3
min. The specific enzymatic activity was then calculated from the Beer–Lambert law using the molar
extinction coefficient of cytochrome c (18.5 L/mmol/cm) and expressed in nmol/min/mg of protein.
2.8. Mitochondrial Bioenergetics Analysis
Mitochondrial respiration was determined using a Seahorse XF24e extracellular flux analyzer
(Seahorse Bioscience, Agilent Technologies France, Les Ulis, France) as per the manufacturer’s instructions
and as described in [27]. Briefly, human VSMCs were plated into XF24 plates (100777-004, Seahorse
Bioscience) at 40,000 cells per well in a DMEM medium and were allowed to adhere for 24 h. The basal
oxygen consumption rate (OCR) was determined, and then oligomycin (1 µM), FCCP (1 µM) and
antimycin A/rotenone (1 µM) were sequentially added to measure basal respiration, maximal respiration,
ATP production and spare respiratory capacity. For normalization, cells were lysed in the XF24 plates using
a protein lysis buffer (50 µL/well), and protein concentration was determined using the Bradford method.
2.9. Confocal Imaging of MitoTimer and Ratiometric Analysis
Cells grown on glass coverslips were transiently transfected with MitoTimer plasmid in a DMEM
serum free medium using the GeneCellin reagent (GC1000, Eurobio, Les Ulis, France) according to the
manufacturer’s instructions. After treatments, cells were fixed, the coverslips were mounted on glass slides,
and images were acquired by confocal microscopy (Zeiss LSM780, Zeiss, Marly le Roi, France) for both
green (excitation/emission 483/500 nm) and red (excitation/emission 558/583 nm) channels [28]. Images
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were then analyzed with Image J software; green and red channels were merged as a single binarized
image to detect all mitochondria, and a mask was created from it to measure the mean fluorescence
intensity for each mitochondrion, both in the green and red channels. A measurement of the red/green ratio
then allowed us to determine the oxidative status of mitochondria (ratiometric image). For the assessment
of mitochondria and PACS-2 colocalization, a pixel colocalization was performed, and mitochondria were
then classified according to their colocalization with PACS-2 as their red/green ratio level.
2.10. Mitophagy Flux Assessment Using Flow Cytometry
Cells plated into 6-well plates were stained in a medium with 10 nM of MitoTracker Deep Red
(MitoTR) (M22426, Invitrogen) for 15 min at 37 ◦C, washed and trypsinized for 5 min at 37 ◦C, and then
resuspended in PBS. Using an LSRFortessa flow cytometer (Becton Dickinson, Franklin Lakes, NJ,
USA) 20,000 cells were acquired (FACSDiva software, BD FACSDiva v8.0.1, Becton Dickinson), and the
data were analyzed using the single cell analysis software FlowJo. The mean fluorescence (FL4 channel)
in the viable cell population was plotted and normalized against that of untreated cells as described
in [29]. Mitophagy flux compares the MitoTR levels with and without lysosomal inhibitors and is
calculated as the ratio of MitoTR fluorescence in the presence of lysosomal inhibitors to that in the
absence of inhibitors, normalized to the corresponding value in control cells.
2.11. Annexin V/propidium Iodide and FACS Analyses
After oxidized LDL stimulation, cells were collected, resuspended, and stained with dyes of the
Annexin V FITC Detection Kit (Eurobio, ABC500FI, Les Ulis, France) according to the manufacturer’s
instructions and as described in [23]. Cells were then analyzed using a FACSVerse flow cytometer
(Becton Dickinson). The percentage of Annexin V positive (and propidium iodide positive or negative)
cells was determined and compared between the different conditions.
2.12. Statistical Analyses
Results are expressed as the mean ± SEM. The data normality distribution was assessed using
the Shapiro–Wilk normality test. Parametric tests were realized when the data assumed the normal
distribution assumption if not non-parametric tests were applied. The differences between two groups
were analyzed with unpaired Student’s t-test, Wilcoxon or Mann–Whitney tests. Differences between
more than two groups were analyzed by the Kruskal–Wallis test and followed by Dunn’s post-hoc test
or two-way ANOVA, followed by Tukey’s or Holm–Sidak’s post-hoc tests if there was a significant
interaction between groups. All statistical analyses were performed using GraphPad Prism software (v
6.01, GraphPad Software, San Diego, CA, USA).
3. Results
3.1. The Sorting Protein PACS-2 Accumulates at Mitochondria-ER Contact Sites in Response to Oxidized LDL
in Human VSMCs
Firstly, we sought to examine whether the number of mitochondria-ER contacts in human VSMCs
(hVSMCs) are increased upon cell stimulation with oxidized lipids (oxidized low-density lipoproteins,
oxidized LDL). The colocalization area between mitochondria labelled with the translocase of outer
membrane 20 (Tom20) and the ER marker KDEL was measured by confocal microscopy and showed
a two-fold significant increase compared to the baseline condition (Figure 1a,b). For higher resolution
analysis, the mitochondria-ER contacts were measured by high-resolution STED confocal microscopy,
which allows for at least a 20 nm lateral resolution and a 40–50 nm axial resolution in comparison to the
200 nm lateral resolution limit of classical confocal microscopy (Figure 1c). A significant increase of the
mitochondria-ER contacts upon oxidized LDL treatment was still detected (Figure 1d). The calculation of the
Pearson’s correlation coefficient (0.28 versus 0.63) confirmed that there is a significant association between
mitochondria and the ER in oxidized LDL-stimulated hVSMCs compared to baseline conditions (Figure 1e).
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Figure 1. Mitochondria-ER contact sites are increased in response to oxidized low-density lipoproteins
(LDL) stimulation in human vascular smooth muscle cells (hVSMCs). (a) Representative images of
mitochondria (Tom20, red) and ER (KDEL, green) contacts in hVSMCs at baseline conditions (Control)
or stimulated with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with an LSM
780 confocal microscope, scale bar 20 µm, zoom scale bar 10 µm. (b) Analysis of the colocalization area
between mitochondria and ER using Image J software. The graph represents the mean ± SEM of 10 cells
analyzed per experiment for each condition (n = 3; Student’s t test, *** p < 0.001). (c) Representative images
of mitochondria (Tom20, magenta) and ER (KDEL, green) contacts in hVSMCs at baseline conditions
(Control) or stimulated with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with the
high-resolutive stimulated emission depletion (STED) technology on a SP8 confocal microscope, scale
bar 5 µm. (d) The colocalization area between mitochondria and ER and (e) the Pearson’s colocalization
coefficient were measured with Image J software. The graphs represent the mean± SEM of 8 cells analyzed
per experiment for each condition (n = 3; Student’s t and Mann–Whitney tests, * p < 0.05, ** p < 0.01).
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The sorting protein PACS-2 is involved not only in the tethering between mitochondria and the
ER but also in the control of cell fate at mitochondria-ER contact sites [9,30]. However, the potential
role of PACS-2 as a check point for MAM formation in hVSMCs, as well as for their cell fate,
has not been reported. We first checked the expression of PACS-2 at MAM sites in hVSMCs.
Triple-color imaging demonstrated the MAM localization of PACS-2 in hVSMCs (Figure 2a) in
addition to its significant accumulation at MAM sites under oxidized LDL stimulation (Figure 2b).
Moreover, PACS-2 accumulation at MAM sites was independent to an increase of its protein expression
level (Figure 2c,d). We further assessed the requirement of PACS-2 for the oxidized LDL-induced
changes in interacting MAM proteins by using the in situ PLA, a recently developed method [31]
allowing for the visualization and quantification of protein–protein interactions ranging from 0 to
40 nm through dual antibody recognition. For the interactions between VDAC1 and IP3R1 (Figure 2e)
or VDAC1 and Grp75 (Figure S1a), three organelle-surface proteins at the MAM interface were
detected as intracellular fluorescent red dots. The number of PLA dots per cell was increased in
oxidized LDL stimulated-hVSMCs but significantly prevented after PACS-2 silencing (Figure 2e–f,
Figure S1a,b). The specificity of the assay was also demonstrated by the inhibition of VDAC1/IP3R1
and VDAC1/Grp75 interactions after MFN2 silencing (Figure 2e–f, Figure S1a,b).
3.2. Dysfunctional Mitochondria Induce the Formation of Mitochondria-ER Contact Sites
We next asked whether the formation of MAMs induced by the treatment of hVSMCs with
oxidized LDL is linked to a mitochondrial dysfunction. The specific activity of mitochondrial
respiratory complexes I and III following treatment of hVSMCs with oxidized LDL was significantly
impaired compared to untreated cells that used the mitochondrial oxidative phosphorylation uncoupler
CCCP (Figure 3a). Mitochondrial bioenergetic functions were assessed using a Seahorse extracellular
flux analyzer that measures the mitochondrial oxygen consumption rate (OCR) as an indicator of
respiratory reserve capacity after uncoupling electron transport. Basal and maximal respiration, as well
as ATP production, were each significantly reduced in oxidized LDL-stimulated hVSMCs compared
to control conditions (Figure 3b,c). Since we recently identified the selective degradation of altered
mitochondria by mitophagy as a safeguard mechanism against hVSMC apoptosis and because the site
of mitophagosome biogenesis has been described at MAM contacts in yeast [22], we then investigated
whether the altered mitochondria could be preferentially located at MAMs.
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Figure 2. Phosphofurin acidic cluster sorting protein 2 (PACS-2) accumulates at mitochondria-ER 
contact sites in response to oxidized LDL in hVSMCs and is required for mitochondria-associated ER 
membranes (MAM) interaction. (a) Representative images of mitochondria (Mitotracker Deep Red, 
MTDR, magenta), ER (KDEL, red) and PACS-2 (green) in hVSMCs at baseline conditions (Control) or 
stimulated with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with an LSM 
780 confocal microscope, scale bar 5 µm. (b) Analysis of the colocalization area between mitochondria, 
ER, and PACS-2 using Image J software. The graph represents the mean ± SEM of 10 cells analyzed 
per experiment for each condition (n = 3, Mann–Whitney test, *** p < 0.001). (c) Western-blot analysis 
of PACS-2 time course expression in hVSMCs stimulated with oxidized LDL (oxLDL, 200 µg 
ApoB/mL). (d) The graph represents the densitometric analysis of the expression level of the PACS-2 
protein. The data are expressed as mean ± SEM of four independent experiments (one-way ANOVA 
test, ns, non-significant). (e) (right panel), western-blot analysis of PACS-2 and mitofusin 2 (MFN2) 
expression levels in hVSMCs after siRNA transfection (scr, scrambled); (left panel), Representative 
images of the interactions between two MAM proteins, voltage-dependent anion channel 1 (VDAC1) 
and inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) (red dots), obtained by a proximity ligation 
assay (PLA). hVSMCs were transfected with scrambled siRNA (siScr), PACS-2 siRNA (siPACS-2) or 
MFN2 siRNA (siMFN2) and stimulated or not with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). 
Images were obtained with an LSM 780 confocal microscope. (f) The number of VDAC1/IP3R1 
Figure 2. Phosphofurin acidic cluster sorting protein 2 (PACS-2) accumulates at mitochondria-ER contact
sites in response to oxidized LDL in hVSMCs and is required for mitochondria-associated ER membranes
(MAM) interaction. (a) Representative images of mitochondria (Mitotracker Deep Red, MTDR, magenta),
ER (KDEL, red) and PACS-2 (green) in hVSMCs at baseline conditions (Control) or stimulated with oxidized
LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with an LSM 780 confocal microscope, scale
bar 5 µm. (b) Analysis of the colocalization area between mitochondria, ER, and PACS-2 using Image J
software. The graph represents the mean ± SEM of 10 cells analyzed per experiment for each condition (n =
3, Mann–Whitney test, *** p < 0.001). (c) Western-blot analysis of PACS-2 time course expression in hVSMCs
stimulated with oxidized LDL (oxLDL, 200µg ApoB/ L). (d) The graph repres nts the d nsitometric analysis
of the expression level of the PACS-2 protei . The data are expressed as mean ± SEM of four independent
experiments (one-way ANOVA test, ns, non-significant). (e) (right panel), western-blot analysis of PACS-2
and mitofusin 2 (MFN2) expression levels in hVSMCs after siRNA transfection (scr, scrambled); (left panel),
Representative images of the interactions between two MAM proteins, voltage-dependent anion channel 1
(VDAC1) and inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) (red dots), obtained by a proximity ligation
assay (PLA). hVSMCs were transfected with scrambled siRNA (siScr), PACS-2 siRNA (siPACS-2) or MFN2
siRNA (siMFN2) and stimulated or not with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were
obtained with an LSM 780 confocal microscope. (f) The number of VDAC1/IP3R1 interactions per cell
was analyzed using Image J software, the graph represents the mean ± SEM of 10 wide field images per
experiment for each condition (n = 3; two-way ANOVA with treatment (*) and siRNA (#) as category factors
and Tukey’s post-hoc test, ** p < 0.01, ### p < 0.001, ns, non-significant).
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Figure 3. Dysfunctional mitochondria form MAM contact sites in response to oxidized LDL. (a) Respiratory
chain complexes I+III activities were measured in hVSMCs treated or not (Control) with oxidized LDL (oxLDL,
200 µg ApoB/mL, 5 h) or carbonyl cyanide 3-chlorophenylhydrazone (CCCP) (20 µM). The graph represents
the mean ± SEM of the absorbance at 550 nm of reduced cytochrome c in presence of NADH substrate (n
= 4; Kruskall–Wallis test, * p < 0.05, ** p < 0.01). (b) Seahorse profile for oxygen consumption rate (OCR) in
hVSMCs treated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h) following treatment with
oligomycin, carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and antimycin A/rotenone. Data
are the mean ± SEM (n = 5). (c) Graphs represent the basal respiration (last rate measurement before first
injection—non mitochondrial respiration rate), the maximal respiration (maximal rate measurement after
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FCCP injection—non mitochondrial respiration rate), and ATP production (last rate measurement before
first injection—minimum rate measurement after oligomycin injection) in hVSMCs treated or not (Control)
with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Data are the mean ± SEM (n = 5; Wilcoxon test, * p
< 0.05). (d) Imaging of MitoTimer, hVSMCs were transfected with a SIN-PGK-MitoTimer plasmid and
exposed or not (Control) to oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Merged images of the green and
red channels are shown; smaller insets show the green and red channels—scale bar 10 µm. (e) Red/green
fluorescent ratio quantification of 10 cells analyzed per experiment for each condition (mean ± SEM; n =
3, Student’s t test, *** p < 0.001). (f) Representative images of PACS-2 (magenta) and MitoTimer (green
and red) in hVSMCs at baseline conditions (Control) or stimulated with oxidized LDL (oxLDL, 200 µg
ApoB/mL, 5 h). Images were obtained with an LSM 780 confocal microscope, scale bar 5 µm. (g) Red/green
fluorescent ratio quantification was performed for mitochondria colocalized or not with PACS-2. Analyses
were done with Image J software, and the graph represents the mean ± SEM of 10 cells analyzed per
experiment for each condition (n = 3, two-way ANOVA with treatment (*) and mitochondria/PACS-2
colocalization (#) as category factors and Tukey’s post-hoc test, ** p < 0.01, *** p < 0.001, # p < 0.05).
For that, we used the MitoTimer probe, a mitochondria-targeted green fluorescent protein which
shifts irreversibly to red fluorescence when oxidized [28] in combination with the immunofluorescence
detection of PACS-2. MitoTimer-transfected hVSMCs displayed at baseline a predominantly
green mitochondrial network and the treatment with oxidized LDL caused an increase of the
MitoTimer red fluorescence, corroborating the mitochondrial damage previously observed (Figure 3d).
The fluorescence signal intensity in the red and green channels was determined at baseline and after
oxidized LDL stimulation, allowing for the measurement of the red to green ratio, which was
significantly increased in stimulated-hVSMCs compared to the normal condition (Figure 3e).
The quantification of the colocalization between PACS-2 and each MitoTimer-positive mitochondrion
revealed that, based on their higher red/green fluorescence ratio, oxidized LDL stimulated the
association of PACS-2 with oxidized mitochondria. This result suggests that damaged mitochondria
establish contacts with the ER to trigger mitophagosome formation (Figure 3f,g).
Consistent with this hypothesis, we showed that the ER protein oxidoreductase Ero1-Lα, which is
involved in the regulation of redox processes [32], significantly re-localized to MAM contact sites
under oxidized LDL stimulation (Figure S2a,b). Since we previously demonstrated that oxidized LDL
induced an ER stress [24,33], our result suggests that Ero1-Lα could be involved in the control of the
ER redox state to the formation of MAM contacts.
3.3. The Sorting Protein PACS-2 Is Necessary for the Process of Autophagosome Formation during Mitophagy
in hVSMCs
The MAM contact sites are crucial for mitochondria fission and the initiation of autophagosome
formation following mitophagic stimuli [34]. To investigate whether pre-autophagosome markers are
located at MAM sites upon oxidized LDL stimulation, we assessed, by confocal microscopy and PLA,
the colocalization and the interaction between mitochondria, PACS-2, and the pre-autophagosomal
marker Beclin-1. Triple-color imaging demonstrated, in stimulated-hVSMCs, a marked enhancement of
Beclin-1 at MAM sites (Figure 4a,b), as well as an increased number of PLA dots (Figure 4c,d) compared
to the baseline condition. To further substantiate this result, we quantified the fragmentation of
mitochondria and the number of autophagosomes in oxidized LDL stimulated-hVSMCs. As expected,
all these parameters were significantly increased (Figure S3a–c). Moreover, as we previously showed
that the molecular mechanism mediating mitophagy in hVSMCs involved the recruitment of the E3
ubiquitin ligase Parkin to mitochondria, we also searched for the presence of Parkin. Indeed, PLA
quantification showed the significant enhancement of VDAC1/Parkin and MFN2/Parkin interactions
following oxidized LDL stimulation (Figure S3d,e). Interestingly, the increased interactions between
Grp75 and Beclin-1 following oxidized LDL treatment were significantly prevented after PACS-2
silencing, as measured by PLA (Figure 4e,f), thus substantiating the major role of PACS-2 in the process
of autophagosome formation during mitophagy.
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Figure 4. Autophagosome formation during mitophagy requires PACS-2 and MAM contact sites in 
hVSMCs. (a) Representative images of mitochondria (MTDR, magenta), PACS-2 (green) and Beclin-1 
(red) in hVSMCs at baseline conditions (Control) or stimulated with oxidized LDL (oxLDL, 200 µg 
ApoB/mL, 5 h). Images were obtained with an LSM 780 confocal microscope, scale bar 10 µm, zoom 
scale bar 5 µm. (b) Analysis of the colocalization area between mitochondria, PACS-2, and Beclin-1 
Figure 4. Autophagosome formation during itophagy requires PACS-2 and MAM contact sites in
hVSMCs. (a) Representative images of mitochondria (MTDR, magenta), PACS-2 (green) and Beclin-1
(red) in hVSMCs at baseline conditions (Control) or stimulated with oxidized LDL (oxLDL, 200 µg
ApoB/mL, 5 h). Images were obtained with an LSM 780 confocal microscope, scale bar 10 µm, zoom
scale bar 5 µm. (b) Analysis of the colocalization area between mitochondria, PACS-2, and Beclin-1
using Image J software. The graph represents the mean ± SEM of 10 cells analyzed per experiment for
each condition (n = 3, Mann–Whitney test, ** p < 0.01). (c) Representative images of the interactions
between PACS-2 and Beclin-1 (red dots) obtained by a proximity ligation assay (PLA) in hVSMCs
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stimulated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with
an LSM 780 confocal microscope. (d) The number of PACS-2/Beclin-1 interactions per cell was analyzed
using Image J software; the graph represents the mean ± SEM of five wide field images per experiment for
each condition (n = 4; Mann–Whitney test, *** p < 0.001). (e) Representative images of the interactions
between glucose-regulated protein 75 (GRP75) and Beclin-1 (red dots) obtained by proximity ligation
assay (PLA). hVSMCs were transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and
stimulated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 5 h). Images were obtained with
an LSM 780 confocal microscope. (f) The number of GRP75/Beclin-1 interactions per cell was analyzed
using Image J software, the graph represents the mean ± SEM of 5 wide field images per experiment for
each condition (n = 3; two-way ANOVA with treatment (*) and siRNA (#) as category factors and Tukey’s
post-hoc test, ***p < 0.001, ### p < 0.001, ns, non-significant).
3.4. The Absence of PACS-2 Enhances Cell Death and Impairs Mitophagy
We next investigated the outcomes associated with the absence of PACS-2 in hVSMCs in stress
conditions. The consequences on cell fate were illustrated by the significant increased percentage of cell
death in PACS-2-deficient hVSMCs following oxidized LDL treatment, compared to scramble siRNA
transfected cells (Figure 5a). We then asked whether the increase of cell death could be a consequence
of impaired mitophagy. For this purpose, we used a recently validated quantitative method to
measure mitophagic flux by flow cytometry in the presence of lysosomal inhibitors [23,29]. As shown,
the oxidized LDL treatment of hVSMCs reduced MTDR staining indicating increased mitochondria
autophagy, which was prevented by the treatment with the lysosomal inhibitor bafilomycin A1 (BafA1).
Notably, the MTDR signal measured in PACS-2-deficient hVSMCs treated with or without oxidized
LDL was not significantly different (Figure 5b,c). In addition, the mitophagy flux, defined as the
ratio of MTDR fluorescence in the presence of lysosomal inhibitors to that in the absence of inhibitors
(normalized to the corresponding value in non oxLDL-treated cells), was significantly decreased in
PACS-2-deleted hVSMCs, thus confirming that PACS-2 expression was necessary for the mitophagy
process (Figure 5d). We also checked that the treatment with BafA1 did not interfere with upstream
mitophagy pathway. Accordingly, we still measured an increase in mitochondria-ER contacts in
BafA1 stimulated-hVSMCs following oxidized LDL treatment as well as mitochondria fragmentation
(Figure S4a–c). Moreover, an analysis of autophagic flux by measuring P62 degradation in the presence
of BafA1 or autophagosomes and mitochondria colocalization clearly supports the functional role of
PACS-2 during autophagosome biogenesis (Figure 5e–h).
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Figure 5. PACS-2 deletion enhances hVSMCs death and impairs mitophagy in response to oxidized 
LDL. (a) Cell death assessment by Annexin V/PI staining followed by flow cytometry analysis in 
hVSMCs transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated or 
not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). The graph represents the 
quantitative analysis of the percentage of dead cells, data are expressed as mean ± SEM (n = 5–7; two-
way ANOVA with treatment (*) and siRNA (#) as category factors and Tukey’s post-hoc test, ** p < 
0.01, *** p < 0.001, ## p < 0.01). (b) Representative overlays of mitophagy analysis determined by flow 
cytometry using the MTDR staining. Cells were transfected with scrambled siRNA (siScr) or siRNA 
PACS-2 (siPACS-2) and stimulated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 
h). Cells were treated with or without bafilomycin A1 (BafA1, 100 nM) before analysis to block 
lysosomal degradation and stained with MTDR for flow cytometry analysis. (c) Mitophagy 
assessment in hVSMCs. The graph represents the quantitative analysis of the percentage of MTDR 
fluorescence; data are expressed as mean ± SEM (n = 5–9; two-way ANOVA with treatment (*) and 
siRNA (#) as category factors and Holm–Sidak’s post-hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001, ns, 
non-significant). (d) Mitophagy flux determination (arbitrary unit, a.u.) in hVSMCs transfected with 
scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated with oxidized LDL (oxLDL, 
200 µg ApoB/mL, 8 h) in the presence of bafilomycin A1 (Baf1, 100 nM). Data are expressed as mean 
± SEM (n = 5–9; Student’s t test, * p < 0.05). (e) Western-blot analysis of P62 expression in hVSMCs 
transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated or not 
(Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h) in the presence of bafilomycin A1 (Baf1, 
100 nM). β-actin was used as the loading control. (f) The graph represents the densitometric analysis 
of the expression level of P62. The data are expressed as mean ± SEM of six independent experiments 
(one-way ANOVA and Holm–Sidak’s post-hoc test, * p < 0.05, *** p < 0.001, ns, non-significant). (g) 
Representative images of mitochondria (Tom20, red), autophagosomes (Cyto-ID, green) and nucleus 
(DAPI, blue) in hVSMCs transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and 
stimulated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). Images were obtained 
Figure 5. PACS-2 deletion enhances hVSMCs de t and impairs mitophagy i response to oxidized
LDL. (a) Cell death assessment by Annexin V/PI staining followed by flow cytometry analysis in
hVSMCs transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated or not
(Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). The graph represents the quantitative
analysis of the percentage of dead cells, data are expressed as mea ± SEM (n = 5–7; two-way ANOVA
with treatment (*) and siRNA (#) as category factors and Tukey’s post-hoc test, ** p < 0.01, *** p < 0.001,
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## p < 0.01). (b) Representative overlays of mitophagy analysis determined by flow cytometry using the MTDR
staining. Cells were transfected with scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated
or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). Cells were treated with or without
bafilomycin A1 (BafA1, 100 nM) before analysis to block lysosomal degradation and stained with MTDR for
flow cytometry analysis. (c) Mitophagy assessment in hVSMCs. The graph represents the quantitative analysis
of the percentage of MTDR fluorescence; data are expressed as mean ± SEM (n = 5–9; two-way ANOVA with
treatment (*) and siRNA (#) as category factors and Holm–Sidak’s post-hoc test, * p < 0.05, ** p < 0.01, *** p <
0.001, ns, non-significant). (d) Mitophagy flux determination (arbitrary unit, a.u.) in hVSMCs transfected with
scrambled siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated with oxidized LDL (oxLDL, 200 µg
ApoB/mL, 8 h) in the presence of bafilomycin A1 (Baf1, 100 nM). Data are expressed as mean ± SEM (n = 5–9;
Student’s t test, * p < 0.05). (e) Western-blot analysis of P62 expression in hVSMCs transfected with scrambled
siRNA (siScr) or siRNA PACS-2 (siPACS-2) and stimulated or not (Control) with oxidized LDL (oxLDL, 200
µg ApoB/mL, 8 h) in the presence of bafilomycin A1 (Baf1, 100 nM). β-actin was used as the loading control.
(f) The graph represents the densitometric analysis of the expression level of P62. The data are expressed as
mean ± SEM of six independent experiments (one-way ANOVA and Holm–Sidak’s post-hoc test, * p < 0.05,
*** p < 0.001, ns, non-significant). (g) Representative images of mitochondria (Tom20, red), autophagosomes
(Cyto-ID, green) and nucleus (DAPI, blue) in hVSMCs transfected with scrambled siRNA (siScr) or siRNA
PACS-2 (siPACS-2) and stimulated or not (Control) with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). Images
were obtained with an LSM 780 confocal microscope, scale bar 10 µm. (h) Analysis of the colocalization area
between autophagosomes and mitochondria using Image J software. The graph represents the mean ± SEM
of 10 cells analyzed per experiment for each condition (n = 3, two-way ANOVA with treatment (*) and siRNA
(#) as category factors and Holm–Sidak’s post-hoc test, *** p < 0.001, ### p < 0.001).
We then hypothesized that the re-expression of PACS-2 would reverse the impairment of mitophagy
and decrease cell death. For that, mouse embryonic fibroblasts (MEF) obtained from mice genetically
deleted for PACS-2 (MEF PACS-2−/−) were transfected with a PACS-2 expression vector and stimulated with
oxidized LDL. As shown, cell death was prevented, and mitophagy flux was recovered when cells re-express
PACS-2, thus providing clear evidence on the new role of PACS-2 in the regulation of mitophagosome
formation and cell fate (Figure 6a,b). Altogether, these findings suggest that PACS-2, which promotes
MAM tethering, is a key regulator of autophagosome formation following mitophagic stimuli.
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Figure 6. PACS-2 rescue in PACS-2-deficient cells prevents cell death and restores mitophagy following
oxidized LDL treatment. (a) Cell death assessment by Annexin V/PI staining followed by flow cytometry
analysis, in mouse embryonic fibroblasts (MEF) PACS-2 +/+, MEF PACS-2 −/−, and MEF PACS-2 −/−
transfected with pcDNA3-PACS-2 stimulat d with oxidized LDL (oxLDL, 200 µg ApoB/mL, 8 h). Data
are expressed as mean ± SEM (n = 3; one-way ANOVA and H lm–Sid k’s post-hoc test, * p < 0.05, *** p
< 0.001). (b) Mitophagy flux determination (arbitrary unit, a.u.) in MEF PACS-2 +/+, MEF PACS-2 −/−,
and MEF PACS-2 −/− transfected with pcDNA3-PACS-2 and stimulated with oxidized LDL (oxLDL,
200 µg ApoB/mL, 8 h) in the presence of bafilomycin A1 (Baf1, 100 nM). Data are expressed as mean ±
SEM (n = 6; one-way ANOVA and Holm–Sidak’s post-hoc test, * p < 0.05, *** p < 0.001).
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4. Discussion
Despite recent evidence underlining the importance of mitochondria-ER contact sites in cardiac
tissue physiology, little is known about MAM communication and function in vascular tissues,
including in VSMCs. Whereas mitochondrial dynamics through MFN2 expression have been described
to play a role in VSMC phenotypic switching [35,36], there had been no direct or indirect evidence
about a function of mitochondria-ER contacts in VSMCs. Our data show for the first time that the
sorting protein PACS-2 regulates mitochondria-ER contact formation in human VSMCs stressed with
oxidized lipoproteins. We also provide compelling evidence that PACS-2, as a MAM-related protein,
participates in the mitophagy process in response to oxidized lipoproteins.
Our previous works demonstrated that the successful autophagy of dysfunctional mitochondria
stimulates VSMC survival against pro-apoptotic oxidized lipoproteins [23], whereas defective
autophagy promotes VSMC apoptosis and unstable atherosclerotic plaque phenotype [14].
Interestingly, mitochondrial-ER contacts contribute to general autophagy in mammalian cells through
the cooperation of the organelles that provide lipids for the growth of the isolation membrane [7,8].
However, although efficient mitophagy in yeast depends on the coupling of mitochondria and the
ER through an ERMES complex which colocalizes with sites of mitophagosome biogenesis [22],
it is currently unknown whether an analogous mechanism exists in mammalian cells. The use
of high-resolution fluorescence methods (STED confocal microscopy and proximity ligation assay)
allowed us for the first time: i) To measure an increase in mitochondria-ER contacts in stressed
hVSMCs, and ii) to show that PACS-2 is necessary to establish those organelle contacts. Indeed, the
disruption of ER-mitochondrial contacts by knocking down PACS-2 impairs mitophagosome formation
and favors oxidized lipoproteins-induced cell apoptosis, thus supporting the hypothesis that MAM
integrity is a prerequisite for mitochondria autophagy in mammalian cells. Moreover, our results
are consistent with the work of Hamasaki [8], which showed that PACS-2 knockdown abolished
autophagosme formation. To go further into the significance of mitochondria-ER contact formation
in hVSMCs, we provide evidence that mitochondria turned dysfunctional after being challenged
with oxidized lipoproteins. Indeed, we measured an increase of fragmented mitochondria with
reduced bioenergetic efficiency and more oxidative stress in agreement with our previous results [14].
Consistently, the ER oxidoreductase Ero1-Lα colocalized with PACS-2 and mitochondria, and it also
increased a shift to red fluorescence of a MitoTimer probe upon oxidized lipoproteins stimulation.
Thus, we hypothesize that oxidized dysfunctional mitochondria behave as an attractive signal for the
ER, resulting in the formation of MAM contacts. As alluded to previously, mitochondria-ER contact
sites control cell function, including autophagy activity. Here, we describe a novel pathway where
omegasomes form at MAMs in situation of oxidized lipoproteins-induced mitophagy; in addition,
Beclin-1 and PACS-2 are involved in this process. Interestingly, an enrichment of Beclin-1 and PINK1
in the MAM compartment was recently described in SH-SY5Y cells stably expressing PINK1 and
treated with CCCP [34]. Therefore, it is tempting to speculate that mitochondria-residing Beclin-1
and the ER protein PACS-2 interact to promote inter-organellear tethering and initiate the formation
of the mitophagosome. In addition, the E3 ubiquitin ligase Parkin has been shown to accumulate at
MAMs following glutamate excitotoxicity and to modulate mitochondria-ER communication [37,38].
We previously demonstrated that the molecular mechanism mediating mitophagy in human VSMC
involved the recruitment of PINK1 and Parkin to mitochondria [23]. Our new results showed the
interaction of Parkin with MAM-residing proteins. Consequently, we can propose the following
scheme (Figure 7, scheme) where, through inter-organelle communication, dysfunctional mitochondria
may be sensed by MAMs and be followed by mitophagy induction and removal, thus avoiding cell
death and favoring cell survival.
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